Milestone Scientific (MLSS) Liabilities and Shareholders Equity (2010 - 2026)

Milestone Scientific has disclosed Liabilities and Shareholders Equity across 17 years of filings, most recently posting $8.0 million for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $8.0 million, down 12.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $32.3 million (down 23.2% YoY), and the FY2025 annual result was $7.8 million, down 20.32% from the prior year.
• Liabilities and Shareholders Equity came in at $8.0 million for Q1 2026 at Milestone Scientific, up from $7.8 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $19.1 million in Q1 2022 to a low of $7.8 million in Q4 2025.
• The 5-year median for Liabilities and Shareholders Equity is $11.4 million (2023), against an average of $11.4 million.
• Across the five-year window, Liabilities and Shareholders Equity plunged 35.62% in 2023 and climbed 5.57% in 2024, its largest moves.
• Milestone Scientific's Liabilities and Shareholders Equity stood at $13.7 million in 2022, then retreated by 17.01% to $11.4 million in 2023, then dropped by 13.85% to $9.8 million in 2024, then dropped by 20.32% to $7.8 million in 2025, then advanced by 2.01% to $8.0 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $8.0 million (Q1 2026), $7.8 million (Q4 2025), and $8.5 million (Q3 2025), per Business Quant data.